The Food and Drug Administration issued full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday morning, marking the first time a vaccine against the disease caused by the novel coronavirus pandemic has been given the stamp of approval from regulators.
The vaccine, which was granted FDA emergency use authorization in December, will now be marketed under the name Comirnaty for Americans 16-years-old or older.
.png)
.png)
